Metraipolis › archive › dc_3e1afee51155

Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo — Europe PMC PMID:37871122

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37871122
DOI
10.1371/journal.ppat.1011496
License (as archived)
CC0-1.0
Archived
2026-10-07T12:01:03.722Z
SHA-256 of the archived text
aa795663953aa8fae05f42e989c8748144a4d36c8f0ca863bf55b11dbfabfd9c
Stable URL of this page
https://metraipolis.com/documento/dc_3e1afee51155

How to cite

Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo — Europe PMC PMID:37871122 — Europe PMC (en), https://europepmc.org/article/MED/37871122 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_3e1afee51155 (Metraipolis archive dc_3e1afee51155, sha256 aa795663953aa8fae05f42e989c8748144a4d36c8f0ca863bf55b11dbfabfd9c)
BibTeX
@misc{dc3e1afee51155,
  title = {Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo — Europe PMC PMID:37871122},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37871122},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_3e1afee51155; sha256 aa795663953aa8fae05f42e989c8748144a4d36c8f0ca863bf55b11dbfabfd9c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37871122. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Clostridioides difficile is a leading cause of antibiotic-associated diarrhea and nosocomial infection in the United States. The symptoms of C. difficile infection (CDI) are associated with the production of two homologous protein toxins, TcdA and TcdB. The toxins are considered bona fide targets for clinical diagnosis as well as the development of novel prevention and therapeutic strategies. While there are extensive studies that document these efforts, there are several gaps in knowledge that could benefit from the creation of new research tools. First, we now appreciate that while TcdA sequences are conserved, TcdB sequences can vary across the span of circulating clinical isolates. An understanding of the TcdA and TcdB epitopes that drive broadly neutralizing antibody responses could advance the effort to identify safe and effective toxin-protein chimeras and fragments for vaccine development. Further, an understanding of TcdA and TcdB concentration changes in vivo can guide research into how host and microbiome-focused interventions affect the virulence potential of C. difficile. We have developed a panel of alpaca-derived nanobodies that bind specific structural and functional domains of TcdA and TcdB. We note that many of the potent neutralizers of TcdA bind epitopes within the delivery domain, a finding that could reflect roles of the delivery domain in receptor binding and/or the conserved role of pore-formation in the delivery of the toxin enzyme domains to the cytosol. In contrast, neutralizing epitopes for TcdB were found in multiple domains. The nanobodies were also used for the creation of sandwich ELISA assays that allow for quantitation of TcdA and/or TcdB in vitro and in the cecal and fecal contents of infected mice. We anticipate these reagents and assays will allow researchers to monitor the dynamics of TcdA and TcdB production over time, and the impact of various experimental interventions on toxin production in vivo.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2023 (prima pubblicazione 2023-10-23).
Identificativi: PMID 37871122 · PMCID PMC10621975 · DOI 10.1371/journal.ppat.1011496.
Descrittori MeSH principali: Bacterial Toxins; Single-Domain Antibodies; Clostridioides difficile.
Pagina: https://europepmc.org/article/MED/37871122 — https://doi.org/10.1371/journal.ppat.1011496. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:31:06.781Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.